Inhibition of carbachol stimulated acid secretion by interleukin 1beta in rabbit parietal cells requires protein kinase C

Gut. 2001 Jun;48(6):782-9. doi: 10.1136/gut.48.6.782.

Abstract

Background: Interleukin 1beta (IL-1beta) is a potent inhibitor of gastric acid secretion. Regulatory actions at several levels have previously been demonstrated, including direct inhibition of parietal cell acid secretion. Although IL-1beta may activate several intracellular signalling pathways, the mechanisms responsible for inhibition of carbachol stimulated acid secretion have not been determined.

Aims: To investigate the roles of protein kinase C (PKC) and the sphingomyelinase signalling pathways in the regulation of acid secretion by IL-1beta.

Methods: Rabbit parietal cells were obtained by collagenase-EDTA digestion and centrifugal elutriation. Acid secretion stimulated by carbachol and A23187 (to mimic elevations in intracellular calcium) was assessed by 14C aminopyrine uptake in response to IL-1beta, PKC, and sphingomyelinase manipulation.

Results: IL-1beta inhibited carbachol and A23187 stimulated acid secretion in a dose dependent manner. The inhibitory actions were completely reversed by each of three different PKC inhibitors, staurosporine, H-7, and chelerythrine, as well as by PKC depletion with high dose phorbol ester pretreatment. IL-1beta did not downregulate parietal cell muscarinic receptor. IL-1beta significantly increased membrane PKC activity. Activation of the sphingomyelinase/ceramide pathway had no effect on basal or stimulated acid secretion. The inhibitory action of IL-1beta was independent of protein kinase A and protein kinase G activity.

Conclusions: IL-1beta directly inhibits parietal cell carbachol stimulated acid secretion. This action occurs distal to muscarinic receptor activation and elevations in intracellular calcium and requires PKC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / pharmacology
  • Alkaloids
  • Analysis of Variance
  • Animals
  • Benzophenanthridines
  • Carbachol / antagonists & inhibitors
  • Carbachol / pharmacology*
  • Carcinogens / pharmacology
  • Cell Communication / physiology
  • Cells, Cultured
  • Cholinergic Agonists / pharmacology*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Gastric Acid / physiology*
  • Interleukin-1 / physiology*
  • Parietal Cells, Gastric / drug effects*
  • Parietal Cells, Gastric / physiology
  • Phenanthridines / pharmacology
  • Protein Kinase C / physiology*
  • Rabbits
  • Sphingomyelin Phosphodiesterase / physiology
  • Staurosporine / pharmacology
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Alkaloids
  • Benzophenanthridines
  • Carcinogens
  • Cholinergic Agonists
  • Enzyme Inhibitors
  • Interleukin-1
  • Phenanthridines
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • Carbachol
  • chelerythrine
  • Protein Kinase C
  • Sphingomyelin Phosphodiesterase
  • Staurosporine
  • Tetradecanoylphorbol Acetate